Lab Research Funded by National MS Society Identifies Possible Target for Promoting Myelin Repair
January 08, 2020
January 08, 2020
NEW YORK, Jan. 8 -- The National Multiple Sclerosis Society issued the following news:
A team at the Mayo Clinic has reported that a eliminating a molecule - called PAR1 - promoted repair of nerve-insulating myelin in mice. FDA-approved therapies exist that block PAR1, and if further research confirms this approach, they could potentially be repurposed to test benefits in people with MS. The team is led by Isobel Scarisbrick, PhD (Mayo Clinic, Rochester, MN).
* PAR1 is . . .
A team at the Mayo Clinic has reported that a eliminating a molecule - called PAR1 - promoted repair of nerve-insulating myelin in mice. FDA-approved therapies exist that block PAR1, and if further research confirms this approach, they could potentially be repurposed to test benefits in people with MS. The team is led by Isobel Scarisbrick, PhD (Mayo Clinic, Rochester, MN).
* PAR1 is . . .